Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Phillips

Showing results (171-180 of 234) with videos related to

Pageof 24
Sort By:
Lancet (London, England)|July 11, 2003
Decline in the AIDS and death rates in the EuroSIDA study: an observational studyA Mocroft, B Ledergerber, C Katlama, et al.
Clinical and Experimental Immunology|May 1, 1992
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosisM Bofill, G Janossy, C A Lee, et al.
AIDS Research and Human Retroviruses|October 13, 2005
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfectionA Mocroft, A N Phillips, V Soriano, et al.
HIV Medicine|March 14, 2007
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or deathC Holkmann Olsen, A Mocroft, O Kirk, et al.
Epidemiology and Infection|February 1, 2003
Regional and temporal changes in AIDS in Europe before HAARTA Blaxhult, Z Fox, R Colebunders, et al.
HIV Medicine|April 19, 2003
An audit of antiretroviral treatment use in HIV-infected patients in a London clinic: the limitations of observational databases when auditing antiretroviral treatment useC A Sabin, F C Lampe, C Chaloner, et al.
AIDS (London, England)|November 24, 1999
Regional survival differences across Europe in HIV-positive people: the EuroSIDA studyA Chiesi, A Mocroft, L G Dally, et al.
HIV Medicine|December 14, 2011
Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with menD Dolling, A N Phillips, V Delpech, et al.
AIDS (London, England)|December 12, 2001
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patientsA N Phillips, C Pradier, A Lazzarin, et al.
Infection|June 7, 2014
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in EuropeA Mocroft, P Reiss, A Rakhmanova, et al.
Pageof 24

Showing results (171-180 of 234) with videos related to

Sort By:
Pageof 24
Lancet (London, England)|July 11, 2003
Decline in the AIDS and death rates in the EuroSIDA study: an observational studyA Mocroft, B Ledergerber, C Katlama, et al.
Clinical and Experimental Immunology|May 1, 1992
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosisM Bofill, G Janossy, C A Lee, et al.
AIDS Research and Human Retroviruses|October 13, 2005
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfectionA Mocroft, A N Phillips, V Soriano, et al.
HIV Medicine|March 14, 2007
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or deathC Holkmann Olsen, A Mocroft, O Kirk, et al.
Epidemiology and Infection|February 1, 2003
Regional and temporal changes in AIDS in Europe before HAARTA Blaxhult, Z Fox, R Colebunders, et al.
HIV Medicine|April 19, 2003
An audit of antiretroviral treatment use in HIV-infected patients in a London clinic: the limitations of observational databases when auditing antiretroviral treatment useC A Sabin, F C Lampe, C Chaloner, et al.
AIDS (London, England)|November 24, 1999
Regional survival differences across Europe in HIV-positive people: the EuroSIDA studyA Chiesi, A Mocroft, L G Dally, et al.
HIV Medicine|December 14, 2011
Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with menD Dolling, A N Phillips, V Delpech, et al.
AIDS (London, England)|December 12, 2001
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patientsA N Phillips, C Pradier, A Lazzarin, et al.
Infection|June 7, 2014
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in EuropeA Mocroft, P Reiss, A Rakhmanova, et al.
Pageof 24